SCI
31 August 2024
Circular RNA in cancer
(Nature Reviews Cancer;IF:72.5)
Conn, V.M., Chinnaiyan, A.M. & Conn, S.J. Circular RNA in cancer. Nat Rev Cancer 24, 597–613 (2024). https://doi.org/10.1038/s41568-024-00721-7
Corresponding author: Simon J. Conn , Flinders Health and Medical Research Institute, College of Medicine and Public Health, Flinders University, South Australia, Australia. e-mail: simon.conn@flinders.edu.au
Over the past decade, circular RNA (circRNA) research has evolved into a bona fde research feld shedding light on the functional consequence of this unique family of RNA molecules in cancer. Although the method of formation and the abundance of circRNAs can difer from their cognate linear mRNA, the spectrum of interacting partners and their resultant cellular functions in oncogenesis are analogous. However, with 10 times more diversity in circRNA variants compared with linear RNA variants, combined with their hyperstability in the cell, circRNAs are equipped to infuence every stage of oncogenesis. This is an opportune time to address the breadth of circRNA in cancer focused on their spatiotemporal expression, mutations in biogenesis factors and contemporary functions through each stage of cancer. In this Review, we highlight examples of functional circRNAs in specifc cancers, which satisfy critical criteria, including their physical co-association with the target and circRNA abundance at stoichiometrically valid quantities. These considerations are essential to develop strategies for the therapeutic exploitation of circRNAs as biomarkers and targeted anticancer agents.
在过去的十年中,环状RNA(circRNA)研究已经发展成为一个成熟的研究领域,揭示了这一独特RNA分子家族在癌症中的功能性结果。虽然环状RNA的形成方式和丰度可能与其对应的线性mRNA不同,但它们与之相互作用的伙伴谱系及其在肿瘤发生中的细胞功能却是相似的。然而,环状RNA变体的多样性比线性RNA变体高出十倍,再加上它们在细胞内的超稳定性,使得环状RNA具备影响肿瘤发生每个阶段的潜力。当前正是探讨环状RNA在癌症中的广度的合适时机,特别是其时空表达、生物生成因子的突变以及在癌症各阶段的同期功能。在本综述中,我们重点介绍了在特定癌症中具有功能的环状RNA实例,这些实例满足关键标准,包括其与靶标的物理共伴随性以及环状RNA在化学计量学上有效数量的丰度。这些考虑对于开发将环状RNA作为生物标志物和靶向抗癌药剂的治疗策略至关重要。